Phase I radioimmunotherapy trial with iodine-131-CC49 in metastatic colon carcinoma

Journal of Nuclear Medicine

Volumn 36, Issue 4, 1995, Pages 586-592

  Divgi, C R ^a   Scott, A M ^a   Dantis, L ^a   Capitelli, P ^a   Siler, K ^a   Hilton, S ^a   Finn, R D ^a   Kemeny, N ^a   Kelsen, D ^a   Kostakoglu, L ^a   Schlom, J ^a   Larson, S M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

colorectal carcinoma; hematopoietic toxicity; iodine 131 CC49; radioimmunotherapy

Indexed keywords

IODINE 131;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; COLON CARCINOMA; DOSE RESPONSE; FEMALE; HUMAN; IMAGE ANALYSIS; IMMUNE RESPONSE; MALE; METASTASIS; PATIENT CARE; PRIORITY JOURNAL; RADIOACTIVITY; STATISTICAL ANALYSIS;

ABDOMINAL NEOPLASMS; ADENOCARCINOMA; ADULT; AGED; ANTIGENS, NEOPLASM; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GLYCOPROTEINS; HUMAN; IODINE RADIOISOTOPES; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGE; RADIOIMMUNOTHERAPY; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR MARKERS, BIOLOGICAL;

EID: 0028947670     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)